Response to the comment on "SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies".
Pharmacol Res
; 172: 105863, 2021 10.
Article
in En
| MEDLINE
| ID: mdl-34474101
Full text:
1
Database:
MEDLINE
Main subject:
Cardiovascular System
/
Sodium-Glucose Transporter 2 Inhibitors
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
/
Systematic_reviews
Limits:
Humans
Language:
En
Year:
2021
Type:
Article